Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Workhorse Has a Compelling Story If You Tune Out the News

If you’re worth buying and holding a position in WKHS stock, it has a story that may make it a worthwhile investment.

Novavax May Profit From Life in the Slow Lane

Novavax is attempting to bring a Covid-19 vaccine to market in a new way. This makes NVAX stock a risk with potential rewards.

Now’s the Time for Caution When it Comes to Array Technologies

There are many reasons to believe that Array Technologies stock will be a strong renewable energy investment. That may be-- but maybe not right now.

Nvidia May Need to Get Worse Before it Gets Better

Nvidia stock has a premium valuation but several catalysts may keep buyers interested. But with uncertainty likely to bring the market down, caution is advised.

Don’t Blame the Pandemic For the Problems With Naked Brands

Naked Brands is giving investors every reason to believe they will not be in business much longer, but traders are still giving NAKD stock a look.